# Tedizolid Suppressive Antimicrobial Therapy in a Reference Center

> **NCT04662736** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 17 (actual)

## Conditions studied

- Bone and Joint Infection

## Interventions

- **OTHER:** patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic therapy

## Key facts

- **NCT ID:** NCT04662736
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2021-02-01
- **Final completion:** 2021-04-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2021-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04662736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04662736, "Tedizolid Suppressive Antimicrobial Therapy in a Reference Center". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04662736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*